BOK Financial’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
BC
OIM
CC
CI
TWA
BOK Financial's AXDX Position: Q3 2023 in Review
BOK Financial sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 100 shares — an estimated $810 sold.
BOK Financial first reported a position in AXDX in Q2 2013 and held it in 21 quarters. The position peaked at $310K in Q3 2016. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.
- BOK Financial reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
- BOK Financial sold 100 Accelerate Diagnostics shares in Q3 2023, an estimated $810.
- BOK Financial first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 21 quarters.
- BOK Financial's Accelerate Diagnostics position peaked at $310K in Q3 2016.
- 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.
Based on BOK Financial's 13F filing for Q3 2023, filed 14 Nov 2023.